Compounds > misonidazole
Page last updated: 2024-08-22

misonidazole and Pancreatic Neoplasms

misonidazole has been researched along with Pancreatic Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's2 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamaji, M; Harada, H; Kimura, H; Koizumi, K; Koyasu, S; Nakamoto, Y; Nobashi, T; Sano, K; Togashi, K; Tsuji, Y1
Desco, M; Hernández-Agudo, E; Hidalgo, M; Lopez-Casas, PP; Megías, D; Mondejar, T; Mouron, S; Mulero, F; Quintela-Fandino, M; Sanchez, J; Soto-Montenegro, ML1
Campbell, EM; Ee, H; Francis, RJ; Morandeau, L; Robins, PD; Segard, T; Yusoff, IF1
Colletti, PM; Fanti, S; Nanni, C; Rubello, D1
Battit, GE; Kaufman, SD; Nardi, GL; Orlow, EL; Shipley, WU; Tepper, JE; Warshaw, AL; Wood, WC1
Courtenay, VD; Mills, J; Peacock, JH; Rose, CM; Spooner, D; Stephens, TC1
Chung, YS; Ho, JJ; Inui, A; Kim, YS; Kondo, Y; Sawada, T; Sowa, M1
Abe, M; Baba, N; Manabe, T; Sakaguchi, M; Sasai, K; Shibamoto, Y; Takahashi, M1
Akaishi, S; Kobari, M; Kodera, T; Matsuno, S; Sakamoto, K1
Nardi, GL; Orlow, EL; Shipley, WU; Tepper, JE; Warshaw, AL; Wood, WC1

Trials

2 trial(s) available for misonidazole and Pancreatic Neoplasms

ArticleYear
Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:1

    Topics: Adult; Aged; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed

2013
Pharmacokinetics of intratumoral RK-28, a new hypoxic radiosensitizer.
    International journal of radiation oncology, biology, physics, 1992, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Misonidazole; Pancreatic Neoplasms; Radiation-Sensitizing Agents

1992

Other Studies

8 other study(ies) available for misonidazole and Pancreatic Neoplasms

ArticleYear
Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models.
    Radiology, 2016, Volume: 278, Issue:3

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Hypoxia; Immunohistochemistry; Mice; Misonidazole; Pancreatic Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiographic Image Interpretation, Computer-Assisted; Tomography, X-Ray Computed

2016
Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.
    Molecular oncology, 2016, Volume: 10, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Benzimidazoles; Breast; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Deoxycytidine; Female; Fluorine Radioisotopes; Gemcitabine; Humans; Mice; Mice, Nude; Misonidazole; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Quinolones

2016
PET/CT in the management and prognosis of pancreatic exocrine tumors.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:1

    Topics: Female; Humans; Male; Misonidazole; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed

2013
Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.
    Annals of surgery, 1984, Volume: 200, Issue:3

    Topics: Adult; Aged; Brachytherapy; Electrons; Female; Humans; Intraoperative Period; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Palliative Care; Pancreatic Neoplasms; Radiation, Ionizing

1984
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
    British journal of cancer, 1981, Volume: 43, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pancreatic Neoplasms; Transplantation, Heterologous

1981
Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
    Japanese journal of cancer research : Gann, 1996, Volume: 87, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Humans; Immunotoxins; Iodine Radioisotopes; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunodetection; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured

1996
[Experimental study of the intra-operative radiation therapy in pancreatic cancer].
    Nihon Geka Gakkai zasshi, 1988, Volume: 89, Issue:8

    Topics: Adenocarcinoma; Animals; Cell Division; Combined Modality Therapy; Cricetinae; Intraoperative Care; Mesocricetus; Misonidazole; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage

1988
The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:4

    Topics: Actuarial Analysis; Adenocarcinoma; Combined Modality Therapy; Follow-Up Studies; Humans; Intraoperative Period; Misonidazole; Pancreatic Neoplasms; Tomography, X-Ray Computed

1987